1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Acute Migraine Treatments Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Drugs 1.2.3 Patches 1.2.4 Others 1.3 Market by Application 1.3.1 Global Acute Migraine Treatments Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospital Pharmacies 1.3.3 Drug Stores 1.3.4 Retail Pharmacies 1.3.5 Online Pharmacies 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Acute Migraine Treatments Market Perspective (2016-2027) 2.2 Acute Migraine Treatments Growth Trends by Regions 2.2.1 Acute Migraine Treatments Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Acute Migraine Treatments Historic Market Share by Regions (2016-2021) 2.2.3 Acute Migraine Treatments Forecasted Market Size by Regions (2022-2027) 2.3 Acute Migraine Treatments Industry Dynamic 2.3.1 Acute Migraine Treatments Market Trends 2.3.2 Acute Migraine Treatments Market Drivers 2.3.3 Acute Migraine Treatments Market Challenges 2.3.4 Acute Migraine Treatments Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Acute Migraine Treatments Players by Revenue 3.1.1 Global Top Acute Migraine Treatments Players by Revenue (2016-2021) 3.1.2 Global Acute Migraine Treatments Revenue Market Share by Players (2016-2021) 3.2 Global Acute Migraine Treatments Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Acute Migraine Treatments Revenue 3.4 Global Acute Migraine Treatments Market Concentration Ratio 3.4.1 Global Acute Migraine Treatments Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Acute Migraine Treatments Revenue in 2020 3.5 Acute Migraine Treatments Key Players Head office and Area Served 3.6 Key Players Acute Migraine Treatments Product Solution and Service 3.7 Date of Enter into Acute Migraine Treatments Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Acute Migraine Treatments Breakdown Data by Type 4.1 Global Acute Migraine Treatments Historic Market Size by Type (2016-2021) 4.2 Global Acute Migraine Treatments Forecasted Market Size by Type (2022-2027) 5 Acute Migraine Treatments Breakdown Data by Application 5.1 Global Acute Migraine Treatments Historic Market Size by Application (2016-2021) 5.2 Global Acute Migraine Treatments Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Acute Migraine Treatments Market Size (2016-2027) 6.2 North America Acute Migraine Treatments Market Size by Type 6.2.1 North America Acute Migraine Treatments Market Size by Type (2016-2021) 6.2.2 North America Acute Migraine Treatments Market Size by Type (2022-2027) 6.2.3 North America Acute Migraine Treatments Market Size by Type (2016-2027) 6.3 North America Acute Migraine Treatments Market Size by Application 6.3.1 North America Acute Migraine Treatments Market Size by Application (2016-2021) 6.3.2 North America Acute Migraine Treatments Market Size by Application (2022-2027) 6.3.3 North America Acute Migraine Treatments Market Size by Application (2016-2027) 6.4 North America Acute Migraine Treatments Market Size by Country 6.4.1 North America Acute Migraine Treatments Market Size by Country (2016-2021) 6.4.2 North America Acute Migraine Treatments Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Acute Migraine Treatments Market Size (2016-2027) 7.2 Europe Acute Migraine Treatments Market Size by Type 7.2.1 Europe Acute Migraine Treatments Market Size by Type (2016-2021) 7.2.2 Europe Acute Migraine Treatments Market Size by Type (2022-2027) 7.2.3 Europe Acute Migraine Treatments Market Size by Type (2016-2027) 7.3 Europe Acute Migraine Treatments Market Size by Application 7.3.1 Europe Acute Migraine Treatments Market Size by Application (2016-2021) 7.3.2 Europe Acute Migraine Treatments Market Size by Application (2022-2027) 7.3.3 Europe Acute Migraine Treatments Market Size by Application (2016-2027) 7.4 Europe Acute Migraine Treatments Market Size by Country 7.4.1 Europe Acute Migraine Treatments Market Size by Country (2016-2021) 7.4.2 Europe Acute Migraine Treatments Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Acute Migraine Treatments Market Size (2016-2027) 8.2 Asia-Pacific Acute Migraine Treatments Market Size by Type 8.2.1 Asia-Pacific Acute Migraine Treatments Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Acute Migraine Treatments Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Acute Migraine Treatments Market Size by Type (2016-2027) 8.3 Asia-Pacific Acute Migraine Treatments Market Size by Application 8.3.1 Asia-Pacific Acute Migraine Treatments Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Acute Migraine Treatments Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Acute Migraine Treatments Market Size by Application (2016-2027) 8.4 Asia-Pacific Acute Migraine Treatments Market Size by Region 8.4.1 Asia-Pacific Acute Migraine Treatments Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Acute Migraine Treatments Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Acute Migraine Treatments Market Size (2016-2027) 9.2 Latin America Acute Migraine Treatments Market Size by Type 9.2.1 Latin America Acute Migraine Treatments Market Size by Type (2016-2021) 9.2.2 Latin America Acute Migraine Treatments Market Size by Type (2022-2027) 9.2.3 Latin America Acute Migraine Treatments Market Size by Type (2016-2027) 9.3 Latin America Acute Migraine Treatments Market Size by Application 9.3.1 Latin America Acute Migraine Treatments Market Size by Application (2016-2021) 9.3.2 Latin America Acute Migraine Treatments Market Size by Application (2022-2027) 9.3.3 Latin America Acute Migraine Treatments Market Size by Application (2016-2027) 9.4 Latin America Acute Migraine Treatments Market Size by Country 9.4.1 Latin America Acute Migraine Treatments Market Size by Country (2016-2021) 9.4.2 Latin America Acute Migraine Treatments Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Acute Migraine Treatments Market Size (2016-2027) 10.2 Middle East & Africa Acute Migraine Treatments Market Size by Type 10.2.1 Middle East & Africa Acute Migraine Treatments Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Acute Migraine Treatments Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Acute Migraine Treatments Market Size by Type (2016-2027) 10.3 Middle East & Africa Acute Migraine Treatments Market Size by Application 10.3.1 Middle East & Africa Acute Migraine Treatments Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Acute Migraine Treatments Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Acute Migraine Treatments Market Size by Application (2016-2027) 10.4 Middle East & Africa Acute Migraine Treatments Market Size by Country 10.4.1 Middle East & Africa Acute Migraine Treatments Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Acute Migraine Treatments Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Amgen 11.1.1 Amgen Company Details 11.1.2 Amgen Business Overview 11.1.3 Amgen Acute Migraine Treatments Introduction 11.1.4 Amgen Revenue in Acute Migraine Treatments Business (2016-2021) 11.1.5 Amgen Recent Development 11.2 Pfizer 11.2.1 Pfizer Company Details 11.2.2 Pfizer Business Overview 11.2.3 Pfizer Acute Migraine Treatments Introduction 11.2.4 Pfizer Revenue in Acute Migraine Treatments Business (2016-2021) 11.2.5 Pfizer Recent Development 11.3 Novartis 11.3.1 Novartis Company Details 11.3.2 Novartis Business Overview 11.3.3 Novartis Acute Migraine Treatments Introduction 11.3.4 Novartis Revenue in Acute Migraine Treatments Business (2016-2021) 11.3.5 Novartis Recent Development 11.4 Eli Lily 11.4.1 Eli Lily Company Details 11.4.2 Eli Lily Business Overview 11.4.3 Eli Lily Acute Migraine Treatments Introduction 11.4.4 Eli Lily Revenue in Acute Migraine Treatments Business (2016-2021) 11.4.5 Eli Lily Recent Development 11.5 AstraZeneca 11.5.1 AstraZeneca Company Details 11.5.2 AstraZeneca Business Overview 11.5.3 AstraZeneca Acute Migraine Treatments Introduction 11.5.4 AstraZeneca Revenue in Acute Migraine Treatments Business (2016-2021) 11.5.5 AstraZeneca Recent Development 11.6 Teva Pharmaceutical 11.6.1 Teva Pharmaceutical Company Details 11.6.2 Teva Pharmaceutical Business Overview 11.6.3 Teva Pharmaceutical Acute Migraine Treatments Introduction 11.6.4 Teva Pharmaceutical Revenue in Acute Migraine Treatments Business (2016-2021) 11.6.5 Teva Pharmaceutical Recent Development 11.7 Allergan 11.7.1 Allergan Company Details 11.7.2 Allergan Business Overview 11.7.3 Allergan Acute Migraine Treatments Introduction 11.7.4 Allergan Revenue in Acute Migraine Treatments Business (2016-2021) 11.7.5 Allergan Recent Development 11.8 Abbott 11.8.1 Abbott Company Details 11.8.2 Abbott Business Overview 11.8.3 Abbott Acute Migraine Treatments Introduction 11.8.4 Abbott Revenue in Acute Migraine Treatments Business (2016-2021) 11.8.5 Abbott Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Acute Migraine Treatments Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Drugs Table 3. Key Players of Patches Table 4. Key Players of Others Table 5. Global Acute Migraine Treatments Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Acute Migraine Treatments Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Acute Migraine Treatments Market Size by Regions (2016-2021) & (US$ Million) Table 8. Global Acute Migraine Treatments Market Share by Regions (2016-2021) Table 9. Global Acute Migraine Treatments Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 10. Global Acute Migraine Treatments Market Share by Regions (2022-2027) Table 11. Acute Migraine Treatments Market Trends Table 12. Acute Migraine Treatments Market Drivers Table 13. Acute Migraine Treatments Market Challenges Table 14. Acute Migraine Treatments Market Restraints Table 15. Global Acute Migraine Treatments Revenue by Players (2016-2021) & (US$ Million) Table 16. Global Acute Migraine Treatments Market Share by Players (2016-2021) Table 17. Global Top Acute Migraine Treatments Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Migraine Treatments as of 2020) Table 18. Ranking of Global Top Acute Migraine Treatments Companies by Revenue (US$ Million) in 2020 Table 19. Global 5 Largest Players Market Share by Acute Migraine Treatments Revenue (CR5 and HHI) & (2016-2021) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Acute Migraine Treatments Product Solution and Service Table 22. Date of Enter into Acute Migraine Treatments Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Acute Migraine Treatments Market Size by Type (2016-2021) (US$ Million) Table 25. Global Acute Migraine Treatments Revenue Market Share by Type (2016-2021) Table 26. Global Acute Migraine Treatments Forecasted Market Size by Type (2022-2027) (US$ Million) Table 27. Global Acute Migraine Treatments Revenue Market Share by Type (2022-2027) & (US$ Million) Table 28. Global Acute Migraine Treatments Market Size Share by Application (2016-2021) & (US$ Million) Table 29. Global Acute Migraine Treatments Revenue Market Share by Application (2016-2021) Table 30. Global Acute Migraine Treatments Forecasted Market Size by Application (2022-2027) (US$ Million) Table 31. Global Acute Migraine Treatments Revenue Market Share by Application (2022-2027) & (US$ Million) Table 32. North America Acute Migraine Treatments Market Size by Type (2016-2021) (US$ Million) Table 33. North America Acute Migraine Treatments Market Size by Type (2022-2027) & (US$ Million) Table 34. North America Acute Migraine Treatments Market Size by Application (2016-2021) (US$ Million) Table 35. North America Acute Migraine Treatments Market Size by Application (2022-2027) & (US$ Million) Table 36. North America Acute Migraine Treatments Market Size by Country (2016-2021) & (US$ Million) Table 37. North America Acute Migraine Treatments Market Size by Country (2022-2027) & (US$ Million) Table 38. Europe Acute Migraine Treatments Market Size by Type (2016-2021) (US$ Million) Table 39. Europe Acute Migraine Treatments Market Size by Type (2022-2027) & (US$ Million) Table 40. Europe Acute Migraine Treatments Market Size by Application (2016-2021) (US$ Million) Table 41. Europe Acute Migraine Treatments Market Size by Application (2022-2027) & (US$ Million) Table 42. Europe Acute Migraine Treatments Market Size by Country (2016-2021) & (US$ Million) Table 43. Europe Acute Migraine Treatments Market Size by Country (2022-2027) & (US$ Million) Table 44. Asia-Pacific Acute Migraine Treatments Market Size by Type (2016-2021) (US$ Million) Table 45. Asia-Pacific Acute Migraine Treatments Market Size by Type (2022-2027) & (US$ Million) Table 46. Asia-Pacific Acute Migraine Treatments Market Size by Application (2016-2021) (US$ Million) Table 47. Asia-Pacific Acute Migraine Treatments Market Size by Application (2022-2027) & (US$ Million) Table 48. Asia-Pacific Acute Migraine Treatments Market Size by Region (2016-2021) & (US$ Million) Table 49. Asia-Pacific Acute Migraine Treatments Market Size by Region (2022-2027) & (US$ Million) Table 50. Latin America Acute Migraine Treatments Market Size by Type (2016-2021) (US$ Million) Table 51. Latin America Acute Migraine Treatments Market Size by Type (2022-2027) & (US$ Million) Table 52. Latin America Acute Migraine Treatments Market Size by Application (2016-2021) (US$ Million) Table 53. Latin America Acute Migraine Treatments Market Size by Application (2022-2027) & (US$ Million) Table 54. Latin America Acute Migraine Treatments Market Size by Country (2016-2021) & (US$ Million) Table 55. Latin America Acute Migraine Treatments Market Size by Country (2022-2027) & (US$ Million) Table 56. Middle East & Africa Acute Migraine Treatments Market Size by Type (2016-2021) (US$ Million) Table 57. Middle East & Africa Acute Migraine Treatments Market Size by Type (2022-2027) & (US$ Million) Table 58. Middle East & Africa Acute Migraine Treatments Market Size by Application (2016-2021) (US$ Million) Table 59. Middle East & Africa Acute Migraine Treatments Market Size by Application (2022-2027) & (US$ Million) Table 60. Middle East & Africa Acute Migraine Treatments Market Size by Country (2016-2021) & (US$ Million) Table 61. Middle East & Africa Acute Migraine Treatments Market Size by Country (2022-2027) & (US$ Million) Table 62. Amgen Company Details Table 63. Amgen Business Overview Table 64. Amgen Acute Migraine Treatments Product Table 65. Amgen Revenue in Acute Migraine Treatments Business (2016-2021) & (US$ Million) Table 66. Amgen Recent Development Table 67. Pfizer Company Details Table 68. Pfizer Business Overview Table 69. Pfizer Acute Migraine Treatments Product Table 70. Pfizer Revenue in Acute Migraine Treatments Business (2016-2021) & (US$ Million) Table 71. Pfizer Recent Development Table 72. Novartis Company Details Table 73. Novartis Business Overview Table 74. Novartis Acute Migraine Treatments Product Table 75. Novartis Revenue in Acute Migraine Treatments Business (2016-2021) & (US$ Million) Table 76. Novartis Recent Development Table 77. Eli Lily Company Details Table 78. Eli Lily Business Overview Table 79. Eli Lily Acute Migraine Treatments Product Table 80. Eli Lily Revenue in Acute Migraine Treatments Business (2016-2021) & (US$ Million) Table 81. Eli Lily Recent Development Table 82. AstraZeneca Company Details Table 83. AstraZeneca Business Overview Table 84. AstraZeneca Acute Migraine Treatments Product Table 85. AstraZeneca Revenue in Acute Migraine Treatments Business (2016-2021) & (US$ Million) Table 86. AstraZeneca Recent Development Table 87. Teva Pharmaceutical Company Details Table 88. Teva Pharmaceutical Business Overview Table 89. Teva Pharmaceutical Acute Migraine Treatments Product Table 90. Teva Pharmaceutical Revenue in Acute Migraine Treatments Business (2016-2021) & (US$ Million) Table 91. Teva Pharmaceutical Recent Development Table 92. Allergan Company Details Table 93. Allergan Business Overview Table 94. Allergan Acute Migraine Treatments Product Table 95. Allergan Revenue in Acute Migraine Treatments Business (2016-2021) & (US$ Million) Table 96. Allergan Recent Development Table 97. Abbott Company Details Table 98. Abbott Business Overview Table 99. Abbott Revenue in Acute Migraine Treatments Business (2016-2021) & (US$ Million) Table 100. Abbott Recent Development Table 101. Research Programs/Design for This Report Table 102. Key Data Information from Secondary Sources Table 103. Key Data Information from Primary Sources List of Figures Figure 1. Global Acute Migraine Treatments Market Share by Type: 2020 VS 2027 Figure 2. Drugs Features Figure 3. Patches Features Figure 4. Others Features Figure 5. Global Acute Migraine Treatments Market Share by Application: 2020 VS 2027 Figure 6. Hospital Pharmacies Case Studies Figure 7. Drug Stores Case Studies Figure 8. Retail Pharmacies Case Studies Figure 9. Online Pharmacies Case Studies Figure 10. Acute Migraine Treatments Report Years Considered Figure 11. Global Acute Migraine Treatments Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 12. Global Acute Migraine Treatments Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Acute Migraine Treatments Market Share by Regions: 2020 VS 2027 Figure 14. Global Acute Migraine Treatments Market Share by Regions (2022-2027) Figure 15. Global Acute Migraine Treatments Market Share by Players in 2020 Figure 16. Global Top Acute Migraine Treatments Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Migraine Treatments as of 2020 Figure 17. The Top 10 and 5 Players Market Share by Acute Migraine Treatments Revenue in 2020 Figure 18. Global Acute Migraine Treatments Revenue Market Share by Type (2016-2021) Figure 19. Global Acute Migraine Treatments Revenue Market Share by Type (2022-2027) Figure 20. North America Acute Migraine Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 21. North America Acute Migraine Treatments Market Share by Type (2016-2027) Figure 22. North America Acute Migraine Treatments Market Share by Application (2016-2027) Figure 23. North America Acute Migraine Treatments Market Share by Country (2016-2027) Figure 24. United States Acute Migraine Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Canada Acute Migraine Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Acute Migraine Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe Acute Migraine Treatments Market Share by Type (2016-2027) Figure 28. Europe Acute Migraine Treatments Market Share by Application (2016-2027) Figure 29. Europe Acute Migraine Treatments Market Share by Country (2016-2027) Figure 30. Germany Acute Migraine Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. France Acute Migraine Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. U.K. Acute Migraine Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Italy Acute Migraine Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Russia Acute Migraine Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Nordic Acute Migraine Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Acute Migraine Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific Acute Migraine Treatments Market Share by Type (2016-2027) Figure 38. Asia-Pacific Acute Migraine Treatments Market Share by Application (2016-2027) Figure 39. Asia-Pacific Acute Migraine Treatments Market Share by Region (2016-2027) Figure 40. China Acute Migraine Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Japan Acute Migraine Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. South Korea Acute Migraine Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Southeast Asia Acute Migraine Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. India Acute Migraine Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Australia Acute Migraine Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Acute Migraine Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America Acute Migraine Treatments Market Share by Type (2016-2027) Figure 48. Latin America Acute Migraine Treatments Market Share by Application (2016-2027) Figure 49. Latin America Acute Migraine Treatments Market Share by Country (2016-2027) Figure 50. Mexico Acute Migraine Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Brazil Acute Migraine Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Acute Migraine Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa Acute Migraine Treatments Market Share by Type (2016-2027) Figure 54. Middle East & Africa Acute Migraine Treatments Market Share by Application (2016-2027) Figure 55. Middle East & Africa Acute Migraine Treatments Market Share by Country (2016-2027) Figure 56. Turkey Acute Migraine Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Saudi Arabia Acute Migraine Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. UAE Acute Migraine Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. Amgen Revenue Growth Rate in Acute Migraine Treatments Business (2016-2021) Figure 60. Pfizer Revenue Growth Rate in Acute Migraine Treatments Business (2016-2021) Figure 61. Novartis Revenue Growth Rate in Acute Migraine Treatments Business (2016-2021) Figure 62. Eli Lily Revenue Growth Rate in Acute Migraine Treatments Business (2016-2021) Figure 63. AstraZeneca Revenue Growth Rate in Acute Migraine Treatments Business (2016-2021) Figure 64. Teva Pharmaceutical Revenue Growth Rate in Acute Migraine Treatments Business (2016-2021) Figure 65. Allergan Revenue Growth Rate in Acute Migraine Treatments Business (2016-2021) Figure 66. Abbott Revenue Growth Rate in Acute Migraine Treatments Business (2016-2021) Figure 67. Bottom-up and Top-down Approaches for This Report Figure 68. Data Triangulation Figure 69. Key Executives Interviewed

Amgen Pfizer Novartis Eli Lily AstraZeneca Teva Pharmaceutical Allergan Abbott